Wennersten André, Meier Xia, Holmin Staffan, Wahlberg Lars, Mathiesen Tiit
Department of Clinical Neuroscience, Section of Neurosurgery, Karolinska Hospital, Stockholm, Sweden.
J Neurosurg. 2004 Jan;100(1):88-96. doi: 10.3171/jns.2004.100.1.0088.
Cultures containing human neural stem and progenitor cells (neurospheres) have the capacity to proliferate and differentiate into the major phenotypes of the adult brain. These properties make them candidates for therapeutic transplantation in cases of neurological diseases that involve cell loss. In this study, long-term cultured and cryopreserved cells were transplanted into the traumatically injured rat brain to evaluate the potential for human neural stem/progenitor cells to survive and differentiate following traumatic injury.
Neural stem/progenitor cell cultures were established from 10-week-old human forebrain. Immunosuppressed adult rats received a unilateral parietal cortical contusion injury, which was delivered using the weight-drop method. Immediately following the injury, these animals received transplants of neural stem/progenitor cells, which were placed close to the site of injury. Two or 6 weeks after the procedure, these animals were killed and their brains were examined by immunohistochemical analysis. At both 2 and 6 weeks postoperatively, the transplanted human cells were found in the perilesional zone, hippocampus, corpus callosum, and ipsilateral subependymal zone of the rats. Compared with the 2-week time point, an increased number of HuN-positive cells was observed at 6 weeks. In addition, at 6 weeks post-injury/transplantation, the cells were noted to cross the midline to the contralateral corpus callosum and into the contralateral cortex. Double labeling demonstrated neuronal and astrocytic, but not oligodendrocytic differentiation. Moreover, the cortex appeared to provide an environment that was less hospitable to neuronal differentiation than the hippocampus.
This study shows that expandable human neural stem/progenitor cells survive transplantation, and migrate, differentiate, and proliferate in the injured brain. These cells could potentially be developed for transplantation therapy in cases of traumatic brain injury.
含有人类神经干细胞和祖细胞(神经球)的培养物具有增殖能力,并能分化为成人大脑的主要表型。这些特性使其成为涉及细胞丢失的神经系统疾病治疗性移植的候选对象。在本研究中,将长期培养和冷冻保存的细胞移植到创伤性损伤的大鼠脑中,以评估人类神经干细胞/祖细胞在创伤性损伤后存活和分化的潜力。
从10周龄的人类前脑建立神经干细胞/祖细胞培养物。免疫抑制的成年大鼠接受单侧顶叶皮质挫伤性损伤,采用重物坠落法造成损伤。损伤后立即将这些动物接受神经干细胞/祖细胞移植,移植细胞置于损伤部位附近。手术后2周或6周,处死这些动物,通过免疫组织化学分析检查它们的大脑。在术后2周和6周时,均在大鼠的损伤周围区、海马、胼胝体和同侧室管膜下区发现了移植的人类细胞。与2周时间点相比,6周时观察到HuN阳性细胞数量增加。此外,在损伤/移植后6周时,注意到细胞穿过中线进入对侧胼胝体和对侧皮质。双重标记显示神经元和星形胶质细胞分化,但少突胶质细胞未分化。此外,与海马相比,皮质似乎提供了一个对神经元分化不太有利的环境。
本研究表明,可扩增的人类神经干细胞/祖细胞在移植后能够存活,并在损伤的大脑中迁移、分化和增殖。这些细胞有可能被开发用于创伤性脑损伤的移植治疗。